MBA Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
MBA Advisors's BMY Position: Q3 2026 in Review
MBA Advisors increased its Bristol-Myers Squibb (BMY) stake by 2.9% in Q3 2026, buying an estimated $12.2K and bringing the position to 6,910 shares worth $431K. The position accounts for 0.14% of the portfolio, ranked #100.
MBA Advisors first reported a position in BMY in Q4 2021 and has held it in 20 quarters since. The position peaked at $775K in Q2 2023. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- MBA Advisors held 6,910 shares of Bristol-Myers Squibb worth $431K as of Q3 2026.
- MBA Advisors bought 193 Bristol-Myers Squibb shares in Q3 2026, an estimated $12.2K.
- Bristol-Myers Squibb made up 0.14% of MBA Advisors's portfolio in Q3 2026, its #100 holding.
- MBA Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 20 quarters since.
- MBA Advisors's Bristol-Myers Squibb position peaked at $775K in Q2 2023.
- 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on MBA Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.